Trade-related policies and access to medicines ICTSD Consultation on trade policy coherence and access to medicines Geneva November 7 th 2006,

Slides:



Advertisements
Similar presentations
Visit African Trade Policy Centre at Dialogue of the Executive Secretaries with the Second Committee October 2007 Abdoulie Janneh, ECA.
Advertisements

Trade and Health National Assessment The World Health Organisations Diagnostic Tool on Trade and Health Presented by: Corinna Hawkes, Consultant
Least Developed Countries: IP Needs Assessment: WIPO, WTO and the LDC needs assessment process under TRIPS WIPO Conference on Building Partnerships for.
Differential pricing and access to medicines: issues and options Andrew Creese Essential Drugs and Medicines Policy Health Technology and Pharmaceuticals.
URUGUAY’s efforts to address synergies among the Conventions Workshop on synergies and cooperation with other conventions 2-4 July 2003 Espoo, Finland.
1 WTO and medicines: from Doha to Cancún Germán Velásquez Essential Drugs and Medicines Policy World Health Organization Geneva, October 2003.
2 nd WIPO Inter-Regional Meeting on South- South Cooperation on Patents, Trademarks, Geographical Indications, Industrial Designs and Enforcement Cairo.
PSD SECRETARIAT RESOURCE PERSON: NIYI LAWAL Medium Term Sectoral Strategies Presentation at the 2009 Stakeholders Budget Harmonization Session.
COMPETITION POLICY AND ECONOMIC DEVELOPMENT PRESENTATION AT CUTS-ARC CAPACITY BUILDING WORKSHOP, LUSAKA 7 TH MARCH, 2011 BY SAJEEV NAIR, COMPETITION POLICY.
Trade and Inclusive Growth : Mechanism for More Inclusive Policy Making Dr. Posh Raj Pandey South Asia Watch on Trade Economics and Environment (SAWTEE),
RECOMMENDATIONS BY INTELLECTUAL PROPERTY LAWYERS ON LEGAL REFORM MOSES NKOMO LL.B, MIP.
Farm to Fork: Exploring Stakeholder Perspectives Ivor O’ Donovan Tony Quinlan Tony Barry WIT.
Western States Energy & Environment Symposium October 27, 2009.
Intellectual Property Rights, Services and Trade Facilitation CARSTEN FINK African/LDCs Ambassadors Seminar on Post-Hong Kong Assessment of the Doha Round,
World Health Organization
Public health, innovation and intellectual property 1 |1 | WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies Global Strategy and Plan.
IGWG process Gaudenz Silberschmidt, Switzerland Public Health, Innovation and Intellectual Property Global strategy and Plan of Action Dr Gaudenz Silberschmidt,
Assessing the impact of TRIPS-plus provisions on Public Healh: Lessons from Latin America David Vivas Eugui WTO Public Forum CSEND Roundtable.
Overview Summary from Africa and ASEAN assistance Dr. Peter Pembleton, UNIDO.
Presentation on Managing for Development Results in Zambia By A. Musunga Director M&E MOFNP - Zambia.
ENHANCING THE POLICY FRAMEWORK FOR SUSTAINABLE ENERGY INVESTMENT Guidance from the OECD to developing and emerging economies Karim Dahou, Investment Division,
The WIPO Development Agenda: An Overview Geneva May, 2009 Esteban Burrone World Intellectual Property Organization.
IPRs serving innovation BioVision April Bibliotheca Alexandrina Ahmed Abdel Latif International Centre for Trade and Sustainable Development.
Jean-Noel Guillossou Program Manager, SSATP SSATP Institutional Framework Annual Meeting, December 2012.
1 A REGIONAL PERSPECTIVE ON COP ISSUES – SESSION 4: DEVELOPMENT AND TRANSFER OF TECHNOLOGY By Angela Katongo Kabuswe.
1 TRADE POLICY MAKING PROCESS IN MALAWI Presentation by Mr. H.J.K. Mandindi Director of Trade, Ministry of Industry and Trade.
Innovation issues and concerns in EPAs negotiations Regional Dialogue on EPAs, Intellectual Property and Sustainable Development ICTSD, ENDA and QUNO Saly,
WHO Perspective on Medicine Patents and FTAs Asian Regional Workshop on FTAs August, 2005, Kuala Lumpur, Malaysia Dr Zafar Mirza Regional Adviser,
Supporting a Better Local Business and Investment Climate – AN OVERVIEW – SIMON WHITE Strategies and Practices Toward a More Enabling Business and Investment.
1 Innovation and innovation policies in developing countries in the framework of PaceNet+ Ludovico Alcorta Director. Research, Statistics and Industrial.
Aid for Trade and Development Aid for Trade and Development Part I Rajan Dhanjee Office of the Director Division on International Trade in Goods and Services,
Zimbabwe CSOs TRIPS and Access to medicines Aulline Mabika-Chapisa.
Coherence in Global Policy Making for Sustainable Economic Development and Poverty Reduction Michele Ruiters, PhD Institute for Global Dialogue (IGD)
UNCTAD 1 OVERVIEW OF THE DOHA WORK PROGRAMME ISSUES TO BE CONSIDERED BY DEVELOPING COUNTRIES Commercial Diplomacy Programme UNCTAD
8 TH -11 TH NOVEMBER, 2010 UN Complex, Nairobi, Kenya MEETING OUTCOMES David Smith, Manager PEI Africa.
Regulation and the Governance Agenda in the 21 st Century Josef Konvitz, Public Governance Directorate.
FEATS Project Malawi: Terms of Reference for Second Phase Research Study A Policy Study of the linkages between Agricultural Productivity and Rural Livelihoods.
Page 1 Implementation of the WTO Decision on TRIPS and Public Health Government of Canada August 2004.
Oil for Development The Norwegian experience
Intellectual Property Rights and Pharmaceuticals (Following Up the ‘Novartis case’ ) Background note prepared for PHM Vic Internet Workshop.
UNCTAD/CD-TFT 1 IP Provisions in Bilateral & Regional Trade Agreements and Public Health ICTSD/QUNO Dinner Discussion on IPRs in Bilateral & Regional Trade.
1 Enabling environments for technology transfer under the UNFCCC Daniele Violetti Programme Officer, Technology Climate Change Secretariat (UNFCCC) UNFCCC.
Session 6: Summary of Discussion A. Institutional Barriers and Potential Solutions 1. Natural environment does not have national or institutional boundaries,
Training Resource Manual on Integrated Assessment Session UNEP-UNCTAD CBTF Process of an Integrated Assessment Session 2.
WHO/OMS Improving and increasing investments in the health outcomes of the poor Macroeconomics and Health in context Dr. Sergio Spinaci, WHO Senegal, February.
The Role of Peer Review in a Multilateral Framework on Competition Policy Andrea Bruce Investment Trade Policy UNCTAD Regional Seminar for Latin America.
TOWARDS BETTER REGULATION: THE ROLE OF IMPACT ASSESSMENT COLIN KIRKPATRICK IMPACT ASSESSMENT RESEARCH CENTRE UNIVERSITY OF MANCHESTER, UK UNECE Symposium.
1 E u r o p e a n C o m m i s s i o nDirectorate General Environment EU Water Initiative The EU Water Inititative The EECCA component.
1 E u r o p e a n C o m m i s s i o nDirectorate General Environment EU Water Initiative The EU Water Inititative The EECCA component National Policy Dialogue.
DEVELOPMENT COOPERATION FRAMEWORK Presentation by Ministry of Finance 10 December 2013.
Regulatory Management and Reform in India Siddhartha Mitra and Vijay Vir Singh.
Luisa Bernal, Massimiliano Riva 11 May, 2010 Trade and Human Development Aligning climate change, food security, and trade policies.
Effective Management of Regulatory Policy C.H. MONTIN Senior regulatory expert
Integrating Innovation and Creativity into National Policies and Strategies: The International Perspectives By Getachew Mengistie, Intellectual property.
South Africa’s Acceptance of the Protocol Amending the TRIPS Agreement Xolelwa Mlumbi- Peter DDG: ITED 24 November 2015.
Public health, innovation and intellectual property 1 |1 | The Global Strategy on Public Health, Innovation and Intellectual Property Technical Briefing.
Towards a Sector Wide Approach (SWAp) for water sector in Lesotho Prepared by T.W. Sepamo Principal Engineer Water and Sanitation. Prepared for EUWI –
Overview of Good Regulatory Practice Kent Shigetomi Office of the U.S. Trade Representative.
WTO and medicines: from Doha to Cancún
Roadmap for Health in All Policies in Sudan
The Diagnostic Toolkit
Local Government in Jamaica
Capacity Building Project for Argentina’s Voluntary Peer Review
Trade-related policies and access to medicines
IP Provisions in Bilateral & Regional Trade Agreements and Public Health ICTSD/QUNO Dinner Discussion on IPRs in Bilateral & Regional Trade Agreements.
Peter Chibatamoto HIV/AIDS Policy Advisor
Summary from Africa and ASEAN assistance Dr. Peter Pembleton, UNIDO
Overview of Good Regulatory Practice
Roadmap for Health in All Policies in Sudan
Enabling environments for technology transfer under the UNFCCC
Presentation transcript:

Trade-related policies and access to medicines ICTSD Consultation on trade policy coherence and access to medicines Geneva November 7 th 2006,

Road map The context The context ICTSD’s Project on trade-related policy coherence and access to medicines ICTSD’s Project on trade-related policy coherence and access to medicines –Objectives of the project –General methodology –Relevant policies and parameters –Outputs and outcomes

The context MDGs: “To Combat HIV/AIDS, Malaria and other diseases” MDGs: “To Combat HIV/AIDS, Malaria and other diseases” WTO: the TRIPS and Public Health Declaration WTO: the TRIPS and Public Health Declaration The Amendment process to Art. 31 f) of the TRIPS Agreement The Amendment process to Art. 31 f) of the TRIPS Agreement Proposals in the WTO Negotiating Group on Market Access (industrial goods) and various requests in the special sessions of the Services Council Proposals in the WTO Negotiating Group on Market Access (industrial goods) and various requests in the special sessions of the Services Council The CIPIH Report The CIPIH Report

The context WHO Assemblies Resolutions 2006 WHO Assemblies Resolutions 2006 –“ to consider the interplay between international trade and health; to take advantage of the potential opportunities and address the potential challenges that trade and trade agreements may have for health” –to apply or establish, where necessary, coordination mechanisms involving ministries of finance, health and trade, and other relevant institutions, to address public health related aspects of international trade” –and (…) to continue collaborating with the competent international organizations in order to support policy coherence between trade and health sectors”

The context What is trade related policy coherence? What is trade related policy coherence? –“Trade policy coherence involves the systemic promotion of mutually reinforcing policy actions across government agencies creating synergies toward achieving agreed objectives” (OECD) What is access to medicines? What is access to medicines? –“Drugs and medicines that satisfy the health needs of the majority of a country’s population and ought to be available at all times, in adequate dosage, and at prices that all individuals can afford” (WHO) The need for a two fold perspective in trade policy coherence: The need for a two fold perspective in trade policy coherence: –the transformation and adequate implementation of international trade obligations into national law and policy bearing in mind national development goals (i.e. health welfare); –the adequate design of domestic policies given the policy space available in WTO Agreements and FTAs.

ICTSD’s project on trade related policy coherence and access to medicines Objective of the Project: Objective of the Project: “enhancing trade related policy coherence in order to facilitate the creation of an enabling framework for sustainable access to essential medicines in developing countries” More specifically the project seeks to: More specifically the project seeks to: –Provide a better understanding of the interface between different trade-related policies impacting access to essential medicines in selected developing countries –Identify mechanisms and policy options for improving trade- related policy coherence in promoting access to medicines in selected developing countries

General methodology: General methodology: –The specific objectives of the project will be achieved through applied policy, legal and economic research and informal multi-stakeholder dialogues at the national level –The project will focus on 3-4 developing countries in Latin America, Asia and Africa –Pre-selected countries could include: Ghana, Jordan, Peru and South Africa –Engagement by national governments and relevant stakeholders is needed for the success of the project Trade-related policy coherence and access to medicines

Some trade related policies to be analyzed: Market access in goods:Market access in goods: 1.Applied tariffs on bulk active ingredients, finished pharmaceutical products and medical devices 2.Existence of exemptions, waivers or reductions in special cases 3.Non tariff barriers Domestic taxes and price regulations:Domestic taxes and price regulations: 1.VAT, other domestic taxes 2.Price controls schemes FDI regimes:FDI regimes: 1.Enabling environment 2.Investment definition and standards of protection 3.Use of performance requirements Competition law and policyCompetition law and policy Trade-related policy coherence and access to medicines

Some trade related policies to be analyzed: Market access and regulation in health related services:Market access and regulation in health related services: 1.Medical and dental services 2.Midwife and nursing services 3.Hospital services 4.Other human health services 5.Health insurance 6.Data transfer Intellectual property regulation:Intellectual property regulation: 1.Parallel imports 2.Compulsory licenses 3.Test data exclusivity 4.The linkage between marketing approval and patent protection 5.Second uses 6.Exceptions and limitations Government procurement regulation:Government procurement regulation: 1.Preferences (price, quality, reliability, local manufactures/providers) 2.Transparency Trade related policy coherence and access to medicines

Other parameters to be taken into the consideration within the general framework but not subject to policy analysis include: Other parameters to be taken into the consideration within the general framework but not subject to policy analysis include: – Geographical and environmental related factors – Political and macroeconomic stability – The rule of law – Population and cultural / anthropological factors – Purchasing capacity – Overall disease burden – Availability of health infrastructure – Availability of human resources in the health sector – Supply capacity in the drug sector – Level of (health related) technological development – Existence of health service delivery systems Trade-related policy coherence and access to medicines

Trade-related policy coherence and access to medicines Outputs: Outputs: –Prepare a methodological note and expert consultations: Identify trade-related policies that have an impact on access to medicines Identify trade-related policies that have an impact on access to medicines Explore ways to measure impact in an empirical manner Explore ways to measure impact in an empirical manner –Undertake national case studies: Map national trade-related policies at the national level Map national trade-related policies at the national level Identify areas where synergies or lack of coherence Identify areas where synergies or lack of coherence Evaluate impact to the extent possible Evaluate impact to the extent possible –Organize national dialogues: Expose national stakeholders to the findings of the studies Expose national stakeholders to the findings of the studies Generate policy recommendations based on the dialogue Generate policy recommendations based on the dialogue –Prepare synthesis report: Comparative analysis of national experiences Comparative analysis of national experiences Compilation of findings and policy recommendations arising from the dialogues Compilation of findings and policy recommendations arising from the dialogues

ICTSD’s project on trade-related policy coherence and access to medicines Outcomes: Outcomes: –Clearer understanding of national trade-related policies and their impact on access to medicines by relevant stakeholders –Identify of mechanisms and policy options for improving trade- related policy coherence in promoting access to medicines –Ultimately, if stakeholders decide to take action based on the recommendations made, there could be domestic policy reform and adjustment for the creation of an enabling trade-related framework for attaining sustainable access to essential medicines –Other international organizations that could also assist in the process of reform and adjustment process include the WHO, UNCTAD, WTO, WB and various civil society organizations